These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32366444)

  • 1. Quantitative Assessment of Contrast Enhancement on Contrast Enhancement Spectral Mammography (CESM) and Comparison With Qualitative Assessment.
    Rudnicki W; Heinze S; Popiela T; Kojs Z; Luczynska E
    Anticancer Res; 2020 May; 40(5):2925-2932. PubMed ID: 32366444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between quantitative assessment of contrast enhancement in contrast-enhanced spectral mammography (CESM) and histopathology-preliminary results.
    Rudnicki W; Heinze S; Niemiec J; Kojs Z; Sas-Korczynska B; Hendrick E; Luczynska E
    Eur Radiol; 2019 Nov; 29(11):6220-6226. PubMed ID: 31089850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Between Enhancement Intensity in Contrast Enhancement Spectral Mammography and Types of Kinetic Curves in Magnetic Resonance Imaging.
    Rudnicki W; Heinze S; Piegza T; Pawlak M; Kojs Z; Łuczyńska E
    Med Sci Monit; 2020 Mar; 26():e920742. PubMed ID: 32173716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
    Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
    Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degree of Enhancement on Contrast Enhanced Spectral Mammography (CESM) and Lesion Type on Mammography (MG): Comparison Based on Histological Results.
    Łuczyńska E; Niemiec J; Hendrick E; Heinze S; Jaszczyński J; Jakubowicz J; Sas-Korczyńska B; Rys J
    Med Sci Monit; 2016 Oct; 22():3886-3893. PubMed ID: 27768681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of contrast-enhanced spectral mammography (CESM) images.
    Perek S; Kiryati N; Zimmerman-Moreno G; Sklair-Levy M; Konen E; Mayer A
    Int J Comput Assist Radiol Surg; 2019 Feb; 14(2):249-257. PubMed ID: 30367322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of background parenchymal enhancement (BPE) on contrast enhanced spectral mammography compared with magnetic resonance imaging.
    Luczynska E; Pawlak M; Piegza T; Popiela TJ; Heinze S; Dyczek S; Rudnicki W
    Ginekol Pol; 2021; 92(2):92-97. PubMed ID: 33448005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions.
    Xing D; Lv Y; Sun B; Xie H; Dong J; Hao C; Chen Q; Chi X
    J Comput Assist Tomogr; 2019; 43(2):245-251. PubMed ID: 30531546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between breast MRI and contrast-enhanced spectral mammography.
    Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
    Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size.
    Fallenberg EM; Dromain C; Diekmann F; Engelken F; Krohn M; Singh JM; Ingold-Heppner B; Winzer KJ; Bick U; Renz DM
    Eur Radiol; 2014 Jan; 24(1):256-64. PubMed ID: 24048724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Contrast-Enhanced Spectral Mammography (CESM) Reduce Benign Breast Biopsy?
    Liew ALF; Lim HMY; Fok ECM; Loke SC; Tan EY; Chong BK; Lee YS; Chan PMY; Chotai N
    Breast J; 2022; 2022():7087408. PubMed ID: 35711887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical value of suspicious calcification in the diagnosis and surgical treatment of breast lesions using contrast-enhanced spectral mammography].
    Sun XF; Xing W; Yu SN; Sha YY; Pan L; Chen Q
    Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(1):42-46. PubMed ID: 31914557
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the Mammography, Contrast-Enhanced Spectral Mammography and Ultrasonography in a Group of 116 patients.
    Luczyńska E; Heinze S; Adamczyk A; Rys J; Mitus JW; Hendrick E
    Anticancer Res; 2016 Aug; 36(8):4359-66. PubMed ID: 27466557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesions.
    Travieso-Aja MDM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Vega Benítez V; Pérez-Luzardo O
    Radiol Med; 2019 Oct; 124(10):1006-1017. PubMed ID: 31250270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.
    Fallenberg EM; Schmitzberger FF; Amer H; Ingold-Heppner B; Balleyguier C; Diekmann F; Engelken F; Mann RM; Renz DM; Bick U; Hamm B; Dromain C
    Eur Radiol; 2017 Jul; 27(7):2752-2764. PubMed ID: 27896471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative staging by multimodal imaging in newly diagnosed breast cancer: Diagnostic performance of contrast-enhanced spectral mammography compared to conventional mammography, ultrasound, and MRI.
    Daniaux M; Gruber L; De Zordo T; Geiger-Gritsch S; Amort B; Santner W; Egle D; Baltzer PAT
    Eur J Radiol; 2023 Jun; 163():110838. PubMed ID: 37080064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between lesion enhancement and breast cancer in contrast-enhanced spectral mammography.
    Boy FNS; Goksu K; Tasdelen I
    Acta Radiol; 2023 Jan; 64(1):74-79. PubMed ID: 34854742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
    Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
    Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Background enhancement in contrast-enhanced spectral mammography (CESM): are there qualitative and quantitative differences between imaging systems?
    Wessling D; Männlin S; Schwarz R; Hagen F; Brendlin A; Olthof SC; Hattermann V; Gassenmaier S; Herrmann J; Preibsch H
    Eur Radiol; 2023 Apr; 33(4):2945-2953. PubMed ID: 36474057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits.
    Houben IPL; Van de Voorde P; Jeukens CRLPN; Wildberger JE; Kooreman LF; Smidt ML; Lobbes MBI
    Eur J Radiol; 2017 Sep; 94():31-37. PubMed ID: 28941757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.